We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.49B
AUM Growth
+$149M
Cap. Flow
-$38.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
20.52%
Holding
268
New
26
Increased
99
Reduced
104
Closed
25

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$19.9M
2
LITE icon
Lumentum
LITE
+$15.1M
3
VKTX icon
Viking Therapeutics
VKTX
+$13.8M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.7M
5
TREE icon
LendingTree
TREE
+$12M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$51.7M
2
SMCI icon
Super Micro Computer
SMCI
+$47.1M
3
CBAY
Cymabay Therapeutics
CBAY
+$25.2M
4
PRVA icon
Privia Health
PRVA
+$14M
5
SMPL icon
Simply Good Foods
SMPL
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 24.99%
3 Industrials 19.42%
4 Financials 9.95%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WFRD icon
76
Weatherford International
WFRD
$5.79B
$13.6M 0.55%
117,724
+6,416
+6% +$651K
TVTX icon
77
Travere Therapeutics
TVTX
$5.27B
$13.5M 0.54%
1,749,401
+703,252
+67% +$5.93M
WHD icon
78
Cactus
WHD
$3.78B
$13.5M 0.54%
269,242
-87,340
-24% -$3.87M
EXPO icon
79
Exponent
EXPO
$3.05B
$13.5M 0.54%
162,917
-45
-0% -$3.72K
RPD icon
80
Rapid7
RPD
$815M
$13.4M 0.54%
273,899
-72,125
-21% -$3.96M
PTLO icon
81
Portillo's
PTLO
$338M
$13.4M 0.54%
942,461
+7,454
+0.8% +$103K
SLNO
82
DELISTED
Soleno Therapeutics
SLNO
$12.9M 0.52%
300,376
+48,223
+19% +$2.18M
SYNA icon
83
Synaptics
SYNA
$4.46B
$12.7M 0.51%
129,672
+76,422
+144% +$8.03M
ATEC icon
84
Alphatec Holdings
ATEC
$1.31B
$12.5M 0.5%
904,946
+419,174
+86% +$6.22M
VC icon
85
Visteon
VC
$2.8B
$12.2M 0.49%
103,404
+1,722
+2% +$201K
CHUY
86
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$12.1M 0.49%
359,888
-98
-0% -$3.35K
SKYT icon
87
SkyWater Technology
SKYT
$1.54B
$11.9M 0.48%
1,173,153
+58,122
+5% +$572K
ZUO
88
DELISTED
Zuora, Inc.
ZUO
$11.8M 0.48%
1,295,378
+25,073
+2% +$218K
CELH icon
89
Celsius Holdings
CELH
$7.41B
$11.1M 0.45%
134,335
-192,379
-59% -$13.2M
HAE icon
90
Haemonetics
HAE
$3.54B
$11.1M 0.45%
130,437
-16,877
-11% -$1.32M
TTI icon
91
TETRA Technologies
TTI
$1.37B
$11.1M 0.45%
2,510,898
-566,790
-18% -$2.35M
OFIX icon
92
Orthofix Medical
OFIX
$468M
$11.1M 0.45%
765,204
+8,018
+1% +$111K
MTDR icon
93
Matador Resources
MTDR
$6.68B
$11M 0.44%
165,246
-46
-0% -$2.73K
TRIN icon
94
Trinity Capital
TRIN
$1.6B
$11M 0.44%
749,530
+5,824
+0.8% +$84K
IMVT icon
95
Immunovant
IMVT
$8.27B
$9.78M 0.39%
302,789
-3,476
-1% -$127K
HLIT icon
96
Harmonic Inc
HLIT
$1.31B
$9.74M 0.39%
724,389
-407,473
-36% -$5.2M
RXO icon
97
RXO
RXO
$4.83B
$9.66M 0.39%
441,611
+5,300
+1% +$114K
FLYW icon
98
Flywire
FLYW
$2.24B
$9.18M 0.37%
+369,995
New +$8.64M
NSSC icon
99
Napco Security Technologies
NSSC
$1.29B
$8.99M 0.36%
223,794
+1,351
+0.6% +$53K
CLDX icon
100
Celldex Therapeutics
CLDX
$2.77B
$8.9M 0.36%
+212,035
New +$8.71M
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Advisers held 268 positions worth $2.49B, up 6.4% from $2.34B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q1 2024 filing shows 26 new, 99 increased, 104 reduced and 25 closed positions. Its largest new stake was Louisiana-Pacific: 276,306 shares worth $23.2M. The largest sale was Immunogen Inc, an estimated $51.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q1 2024 buy was Louisiana-Pacific: 276,306 shares worth $23.2M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $12.7M increase.
  • Emerald Advisers's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $47.1M.
  • Emerald Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $51.7M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.49B portfolio in Q1 2024.
  • Emerald Advisers opened 26 new positions and closed 25 in Q1 2024.
  • Emerald Advisers's portfolio value rose 6.4% quarter-over-quarter to $2.49B.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.